Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy

NCT06568445 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Bronchial Asthma

Interventions

DRUG: Maintenance at initial treatment sequential as-needed therapy with inhaled budesonide-formoterol(Symbicort 160/4.5) ®）
DRUG: as-needed therapy with inhaled budesonide-formoterol (Symbicort 160/4.5) ®）

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine